Fundamentals · 2026-09-09S&P 500ANNUAL BASIS

Medtronic

MDT stock analysis · Health Care · Health Care Equipment

FY 2026-04-24ANNUAL FILINGS
Compare ⇄
These are research estimates based on annual filings. Valuation uses a cash-flow proxy and explicit assumptions; prices are not live. Published valuations use annual periods first filed by the price date, with later restatements retained.
Reference share price · USD
$78.23HISTORICAL SNAPSHOT

As of · fund-implied per-share value

Fund holding value ÷ shares held. Not a live quote; not adjusted for later stock splits.

View SEC fund filing ↗
Estimated issuer market cap
$100.1B

Price × SEC outstanding shares. Shares measured 2026-06-12. Approximate; share and price dates can differ.

View share-count filing ↗
Reviewed debt balance

Reviewed consolidated balance-sheet debt: current debt 1788000000 plus noncurrent debt 26173000000, in USD. Includes current borrowings/current maturities already reported in the current debt line; current borrowings are included once in the capital calculation. Uses debt carrying amounts as presented, including financing leases only where included by the issuer; excludes operating leases and trade/insurance liabilities. This is a book-capital proxy, not fair value or a claim that every other liability is financing debt. Applies only to this reviewed fiscal period. Read the financial statement ↗

Valuation

DCF value

$64.38

Equity cash-flow scenario · SEC outstanding shares at 2026-06-12 · -17.7% versus input cap

How this is calculated ↗
Valuation

Reverse DCF

9.7%

Annual basis · read assumptions below

How this is calculated ↗
Valuation

Relative valuation

35.8%

14 industry peers · median 28.3×

How this is calculated ↗
Valuation

Historical multiples

27.9×

7 annual observations · snapshot P/E 20.9× · -25.1% versus history

How this is calculated ↗
Valuation

Free cash flow yield

5.4%

Annual basis · read assumptions below

How this is calculated ↗
Quality

ROIC / quality

6.8%

Normalized tax · financing-capital proxy

How this is calculated ↗
Valuation

Value composite

70/100

Annual basis · read assumptions below

How this is calculated ↗
Momentum

12–1 price momentum

Split and corporate-action verification is incomplete for these fund observations. Verified adjusted endpoints are required for 12–1 momentum.

Split and corporate-action verification is incomplete for these fund observations. Verified adjusted endpoints are required for 12–1 momentum.

How this is calculated ↗
Investment

Asset growth

1.5%

Annual basis · read assumptions below

How this is calculated ↗
Investment

Net payout yield

4.2%

Annual basis · read assumptions below

How this is calculated ↗
Quality

Accrual quality

-2.7%

Annual basis · read assumptions below

How this is calculated ↗
Momentum

Fundamental momentum

2.5%

Annual basis · read assumptions below

How this is calculated ↗

Follow the cash

ANNUAL · USD

Operating cash flow and reinvestment over time

USD · bar maximum 7.3B2021-04-30: cfo $6,240,000,000.002021-04-30: capex $1,355,000,000.0020212022-04-29: cfo $7,346,000,000.002022-04-29: capex $1,368,000,000.0020222023-04-28: cfo $6,039,000,000.002023-04-28: capex $1,459,000,000.0020232024-04-26: cfo $6,787,000,000.002024-04-26: capex $1,587,000,000.0020242025-04-25: cfo $7,044,000,000.002025-04-25: capex $1,859,000,000.0020252026-04-24: cfo $7,330,000,000.002026-04-24: capex $1,904,000,000.002026
Operating cash flowCapital expenditure

Annual USD. Negative bars use a compressed lower scale. Hover or inspect the financial history table for exact values.

Make the assumptions yours

Personal inputs stay in this browser. Blank fields retain published inputs. Five-year forecast; zero net borrowing. Required return must exceed terminal growth.

How sensitive is the valuation?

DCF per-share sensitivity · includes reviewed preferred and minority-owner claims · rows: required return · columns: growth
Return / Growth3.0%5.0%7.0%
8.0%$80.75$88.11$96.02
10.0%$59.18$64.38$69.97
12.0%$46.69$50.66$54.92

Annual financial history

Open SEC filings ↗
Fiscal year-endRevenueNet incomeOperating cash flowCapital expenditureAssets
2026-04-2436.4B4.8B7.3B1.9B93B
2025-04-2533.5B4.7B7B1.9B91.7B
2024-04-2632.4B3.7B6.8B1.6B90B
2023-04-2831.2B3.8B6B1.5B90.9B
2022-04-2931.7B5.1B7.3B1.4B91B
2021-04-3030.1B3.6B6.2B1.4B93.1B
2020-04-2428.9B4.8B7.2B1.2B90.7B
2019-04-2630.6B4.7B7B1.1B89.7B
2018-04-2730B3.1B4.7B1.1B91.4B

USD, abbreviated. Restated annual history; not a point-in-time backtest. Missing values appear as dashes.

Trace the inputs

MODEL ANNUAL PERIOD
InputValueSEC tag / sourceFiled
revenue36.4BRevenueFromContractWithCustomerExcludingAssessedTax2026-06-18
netIncome4.8BProfitLoss
Explicit consolidated amount, including the portion attributable to noncontrolling interests.
2026-06-18
Parent/common earnings proxy4.8BNetIncomeLoss2026-06-18
cfo7.3BNetCashProvidedByUsedInOperatingActivities2026-06-18
capex1.9BPaymentsToAcquirePropertyPlantAndEquipment2026-06-18
operatingIncome6.5BOperatingIncomeLoss2026-06-18
assets93BAssets2026-06-18
equity50.1BStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Explicit consolidated amount, including the portion attributable to noncontrolling interests.
2026-06-18
Parent book equity proxy49.5BStockholdersEquity2026-06-18
debt28BReviewed manual correction
Reviewed consolidated balance-sheet debt: current debt 1788000000 plus noncurrent debt 26173000000, in USD. Includes current borrowings/current maturities already reported in the current debt line; current borrowings are included once in the capital calculation. Uses debt carrying amounts as presented, including financing leases only where included by the issuer; excludes operating leases and trade/insurance liabilities. This is a book-capital proxy, not fair value or a claim that every other liability is financing debt. Applies only to this reviewed fiscal period.
2026-06-18
shortDebtNot reported under a supported tag
cash1.9BCashAndCashEquivalentsAtCarryingValue2026-06-18
shares1.3BWeightedAverageNumberOfDilutedSharesOutstanding2026-06-18
dividends3.6BPaymentsOfDividendsCommonStock2026-06-18
buybacks1BPaymentsForRepurchaseOfCommonStock2026-06-18
issuance516MProceedsFromIssuanceOfCommonStock2026-06-18